Your Advocates Ltd’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Your Advocates Ltd’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10	Closed	-$893	–	253
2023 Q4	$893	Hold	10	–	–	﹤0.01%	197
2023 Q3	$730	Hold	10	–	–	﹤0.01%	229
2023 Q2	$832	Hold	10	–	–	﹤0.01%	239
2023 Q1	$762	Hold	10	–	–	﹤0.01%	205
2022 Q4	$830	Hold	10	–	–	﹤0.01%	187
2022 Q3	$1K	Hold	10	–	–	﹤0.01%	191
2022 Q2	$1K	Sell	10 -22	-69%	-$1.65K	﹤0.01%	199
2022 Q1	$3K	Buy	+32	New	+$2.96K	﹤0.01%	167

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Your Advocates Ltd's XBI Position: Q1 2024 in Review

Your Advocates Ltd sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 10 shares — an estimated $893 sold.

Your Advocates Ltd first reported a position in XBI in Q1 2022 and held it in 8 quarters. The position peaked at $3K in Q1 2022. 782 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Your Advocates Ltd reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Your Advocates Ltd sold 10 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $893.
Your Advocates Ltd first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 8 quarters.
Your Advocates Ltd's State Street SPDR S&P Biotech ETF position peaked at $3K in Q1 2022.
782 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Your Advocates Ltd's 13F filing for Q1 2024, filed 1 May 2024.